CELLULARLINE SPA (CELL.MI) Stock Fundamental Analysis
Europe - BIT:CELL - IT0005244618 - Common Stock
2.86 EUR
+0.05 (+1.78%)
We assign a fundamental rating of 5 out of 10 to CELL. CELL was compared to 30 industry peers in the Technology Hardware, Storage & Peripherals industry. CELL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CELL is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CELL was profitable.
In the past year CELL had a positive cash flow from operations.
In multiple years CELL reported negative net income over the last 5 years.
Each year in the past 5 years CELL had a positive operating cash flow.
1.2 Ratios
CELL has a Return On Assets of 2.60%. This is comparable to the rest of the industry: CELL outperforms 60.00% of its industry peers.
Looking at the Return On Equity, with a value of 4.27%, CELL is in the better half of the industry, outperforming 63.33% of the companies in the same industry.
CELL has a Return On Invested Capital (4.42%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.6% | ||
| ROE | 4.27% | ||
| ROIC | 4.42% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 3.44%, CELL perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
In the last couple of years the Profit Margin of CELL has declined.
CELL has a Operating Margin (4.91%) which is in line with its industry peers.
CELL's Operating Margin has declined in the last couple of years.
CELL's Gross Margin of 40.07% is fine compared to the rest of the industry. CELL outperforms 70.00% of its industry peers.
In the last couple of years the Gross Margin of CELL has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.91% | ||
| PM (TTM) | 3.44% | ||
| GM | 40.07% |
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CELL is destroying value.
CELL has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CELL has been reduced compared to 5 years ago.
CELL has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.39 indicates that CELL is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.39, CELL is in line with its industry, outperforming 60.00% of the companies in the same industry.
The Debt to FCF ratio of CELL is 2.46, which is a good value as it means it would take CELL, 2.46 years of fcf income to pay off all of its debts.
CELL has a better Debt to FCF ratio (2.46) than 76.67% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that CELL is not too dependend on debt financing.
The Debt to Equity ratio of CELL (0.13) is better than 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 2.46 | ||
| Altman-Z | 2.39 |
ROIC/WACC0.52
WACC8.48%
2.3 Liquidity
CELL has a Current Ratio of 2.12. This indicates that CELL is financially healthy and has no problem in meeting its short term obligations.
CELL's Current ratio of 2.12 is fine compared to the rest of the industry. CELL outperforms 66.67% of its industry peers.
A Quick Ratio of 1.33 indicates that CELL should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.33, CELL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.33 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 60.78% over the past year.
Measured over the past years, CELL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.43% on average per year.
Looking at the last year, CELL shows a small growth in Revenue. The Revenue has grown by 3.54% in the last year.
CELL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.18% yearly.
EPS 1Y (TTM)60.78%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-4.76%
Revenue 1Y (TTM)3.54%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%-2.91%
3.2 Future
Based on estimates for the next years, CELL will show a small growth in Earnings Per Share. The EPS will grow by 2.47% on average per year.
CELL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.60% yearly.
EPS Next Y-12.5%
EPS Next 2Y2.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.69%
Revenue Next 2Y-0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.00 indicates a reasonable valuation of CELL.
CELL's Price/Earnings ratio is rather cheap when compared to the industry. CELL is cheaper than 90.00% of the companies in the same industry.
CELL is valuated cheaply when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 6.68, which indicates a rather cheap valuation of CELL.
93.33% of the companies in the same industry are more expensive than CELL, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.32. CELL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11 | ||
| Fwd PE | 6.68 |
4.2 Price Multiples
CELL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CELL is cheaper than 93.33% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CELL is valued cheaper than 96.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.19 | ||
| EV/EBITDA | 3.28 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.47%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.25%, CELL has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.37, CELL pays a better dividend. On top of this CELL pays more dividend than 86.67% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, CELL pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.25% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CELL pays out 34.37% of its income as dividend. This is a sustainable payout ratio.
DP34.37%
EPS Next 2Y2.47%
EPS Next 3YN/A
BIT:CELL (10/3/2025, 2:01:47 PM)
2.86
+0.05 (+1.78%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners5.79%
Inst Owner ChangeN/A
Ins Owners19.57%
Ins Owner ChangeN/A
Market Cap62.55M
Analysts82.86
Price Target4.18 (46.15%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.25% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP34.37%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.77%
PT rev (3m)-12.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-28.57%
EPS NY rev (3m)-28.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-11.02%
Revenue NY rev (3m)-11.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11 | ||
| Fwd PE | 6.68 | ||
| P/S | 0.38 | ||
| P/FCF | 4.19 | ||
| P/OCF | 3.08 | ||
| P/B | 0.47 | ||
| P/tB | 1.15 | ||
| EV/EBITDA | 3.28 |
EPS(TTM)0.26
EY9.09%
EPS(NY)0.43
Fwd EY14.98%
FCF(TTM)0.68
FCFY23.85%
OCF(TTM)0.93
OCFY32.45%
SpS7.51
BVpS6.05
TBVpS2.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.6% | ||
| ROE | 4.27% | ||
| ROCE | 5.04% | ||
| ROIC | 4.42% | ||
| ROICexc | 5.33% | ||
| ROICexgc | 12.93% | ||
| OM | 4.91% | ||
| PM (TTM) | 3.44% | ||
| GM | 40.07% | ||
| FCFM | 9.08% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y46.34%
ROICexcg growth 5Y-17.53%
ROICexc growth 3Y77.77%
ROICexc growth 5Y-8.95%
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
F-Score4
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 2.46 | ||
| Debt/EBITDA | 0.81 | ||
| Cap/Depr | 39.19% | ||
| Cap/Sales | 3.28% | ||
| Interest Coverage | 2.77 | ||
| Cash Conversion | 93.13% | ||
| Profit Quality | 264.18% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.33 | ||
| Altman-Z | 2.39 |
F-Score4
WACC8.48%
ROIC/WACC0.52
Cap/Depr(3y)26.8%
Cap/Depr(5y)35.01%
Cap/Sales(3y)3.22%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.78%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-4.76%
EPS Next Y-12.5%
EPS Next 2Y2.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.54%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%-2.91%
Revenue Next Year-5.69%
Revenue Next 2Y-0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.25%
EBIT growth 3Y54.08%
EBIT growth 5Y-17%
EBIT Next Year28.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1050.19%
FCF growth 3Y4.84%
FCF growth 5Y6.28%
OCF growth 1Y730.91%
OCF growth 3Y4.12%
OCF growth 5Y1.2%